Piramal Enterprises is reportedly looking to expand its footprint in its pharma vertical in global markets such as the US, Europe and Japan. In this regards, the company is planning to introduce more products.
The company will continue to add more generic hospital products both organically and inorganically to leverage its strong sales and distribution network, integrating acquired products and generating synergies.
The company generates over 70% of its revenue from pharmaceuticals business in North America and Europe. Its pharma vertical is divided into two - the global pharma business that sells pharma products and services globally and the India consumer products business that sells OTC products in India.
